These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 7653482)

  • 21. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ
    Am J Med; 1998 Mar; 104(3):219-26. PubMed ID: 9552083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of changes in bone mineral in idiopathic and secondary osteoporosis following therapy with cyclical disodium etidronate and high dose calcium supplementation.
    Orme SM; Simpson M; Stewart SP; Oldroyd B; Westmacott CF; Smith MA; Belchetz PE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):245-50. PubMed ID: 7923830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss.
    Mulder H; Struys A
    Br J Rheumatol; 1994 Apr; 33(4):348-50. PubMed ID: 8156307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease.
    Siffledeen JS; Fedorak RN; Siminoski K; Jen H; Vaudan E; Abraham N; Steinhart H; Greenberg G
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):122-32. PubMed ID: 15704046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T; Maekawa S; Morinobu S; Morinobu A; Koshiba M; Yamauchi M; Sugimoto T; Kumagai S
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with etidronate in osteoporosis.
    Ryan PJ; Fogelman I
    Clin Rheumatol; 1994 Sep; 13(3):455-8. PubMed ID: 7835009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
    Masud T; Mulcahy B; Thompson AV; Donnelly S; Keen RW; Doyle DV; Spector TD
    Ann Rheum Dis; 1998 Jun; 57(6):346-9. PubMed ID: 9771208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial.
    Fukunaga M; Kushida K; Kishimoto H; Shiraki M; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H;
    Osteoporos Int; 2002 Dec; 13(12):971-9. PubMed ID: 12459940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of cyclical etidronate on early postmenopausal bone loss: an open, randomized controlled study.
    Heath DA; Bullivant BG; Boiven C; Balena R
    J Clin Densitom; 2000; 3(1):27-33. PubMed ID: 10745299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
    Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A
    J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risedronate improves bone mineral density in Crohn's disease: a two year randomized controlled clinical trial.
    Soo I; Siffledeen J; Siminoski K; McQueen B; Fedorak RN
    J Crohns Colitis; 2012 Aug; 6(7):777-86. PubMed ID: 22398088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty.
    Yamaguchi K; Masuhara K; Yamasaki S; Nakai T; Fuji T
    Bone; 2003 Jul; 33(1):144-9. PubMed ID: 12919709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S; Ohosone Y; Suwa A; Yasuoka H; Nojima T; Fujii T; Kuwana M; Nakamura K; Mimori T; Hirakata M
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
    Harris ST; Watts NB; Jackson RD; Genant HK; Wasnich RD; Ross P; Miller PD; Licata AA; Chesnut CH
    Am J Med; 1993 Dec; 95(6):557-67. PubMed ID: 8259772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
    Ghannam NN; Hammami MM; Bakheet SM; Khan BA
    Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis.
    Crilly RG; Sebaldt RJ; Hodsman AB; Adachi JD; Brown JP; Goldsmith CH; Hanley DA; Olszynski WO; Ste-Marie LG; Stephenson GF
    Osteoporos Int; 2000; 11(7):607-14. PubMed ID: 11069195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.
    Reid DM; Adami S; Devogelaer JP; Chines AA
    Calcif Tissue Int; 2001 Oct; 69(4):242-7. PubMed ID: 11730260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.
    Campbell IA; Douglas JG; Francis RM; Prescott RJ; Reid DM;
    Thorax; 2004 Sep; 59(9):761-8. PubMed ID: 15333852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
    Wolfhagen FH; van Buuren HR; den Ouden JW; Hop WC; van Leeuwen JP; Schalm SW; Pols HA
    J Hepatol; 1997 Feb; 26(2):325-30. PubMed ID: 9059953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.